Stay updated on Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial page.

Latest updates to the Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no study details or user-facing content appear changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1. This appears to be a minor version update.SummaryDifference0.0%

- Check27 days agoChange DetectedThe page added a 'Show glossary' option and new labels such as 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', and removed older phrasing including 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check34 days agoChange DetectedRevision: v3.3.4 is now displayed, replacing the previous v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded a centralized Locations section listing trial sites in Buenos Aires, Santa Fe Province, Estado de Bahia, São Paulo, Região Metro de Santiago, Guangdong, Jalisco, and Gauteng, and removed the previous 'X Locations' subsections. Updated the page revision to v3.3.3.SummaryDifference0.6%

- Check85 days agoChange DetectedAdded Revision: v3.3.2 and removed Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial page.